Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening
American Journal of Epidemiology · 2026
DOI: 10.1093/aje/kwag040 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift American Journal of Epidemiology, 2026. Verfasst von Larry G Kessler und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Systems and Population Health, University of Washington, Seattle, WA, United States. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Breast Neoplasms, Health Surveys. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCCDPHP CDC HHS.
Abstract (Originalsprache)
Background
The National Health Interview Survey (NHIS) is used to measure progress on cancer screening. We assessed validity of questions on cervical, colorectal, breast, and lung cancer screening from the 2020, 2021, and 2022 NHIS, using electronic medical records as our standard for accuracy.
Methods
We surveyed 1,770 adults ages 21+ years for breast, cervical, colorectal, and lung cancer from four US health systems. We made slight changes in question order and wording to improve understanding of questions. We compared survey responses for screening adherence with electronic medical record (EMR) data as a gold standard, calculating sensitivity, specificity, positive predictive value, negative predictive value, Cohen’s Kappa, and reports-to-records ratio.
Results
Self-reported screening adherence had high sensitivity for most cancer types (range 0.79-0.96). We found good agreement for breast cancer screening using Cohen’s Kappa (0.81) and more modest agreement for the other three cancer sites (0.59-0.65). The reports-to-records ratio showed over-reporting cancer screening ranging from 12% to ⁓50% more screening reported for the USPSTF recommended screening periodicity compared to medical record data.
Conclusions
NHIS questions that assess cancer screening provide reasonably accurate estimates. However, some misclassification with expected bias toward over-reporting screening suggests that improvements in measuring screening adherence are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Systems and Population Health, University of Washington, Seattle, WA, United States.
- Department of Biostatistics, University of Washington, Seattle, WA, United States.
- Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, United States.
- Institute for Research and Innovation, MultiCare Health System, Tacoma, WA, United States.
- Department of Epidemiology, University of Washington, Seattle, WA, United States.
- Department of Public Health Sciences, Henry Ford Health, Detroit, MI, United States.
ORCID-Profile: Larry G Kessler, Bryan Comstock, Perla Bravo, Hongyuan Gao, Christine Neslund-Dudas
Förderung
- NCI NIH HHS
- NCCDPHP CDC HHS
Zitieren
APA
Kessler, L. G., Comstock, B., Aiello Bowles, E. J., Mou, J., Nash, M. G., Bravo, P., Fleckenstein, L. E., Pflugeisen, C., Gao, H., Winer, R. L., Ornelas, I. J., Smith, C., Neslund-Dudas, C., Shetty, P., & Raghavan, U. G. (2026). Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening. American Journal of Epidemiology. https://doi.org/10.1093/aje/kwag040
Vancouver
Kessler LG, Comstock B, Aiello Bowles EJ, Mou J, Nash MG, Bravo P, et al. Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening. American Journal of Epidemiology. 2026. doi:10.1093/aje/kwag040
BibTeX
@article{Kessler2026,
author = {Kessler, Larry G and Comstock, Bryan and Aiello Bowles, Erin J and Mou, Jin and Nash, Michael G and Bravo, Perla and Fleckenstein, Lynn E and Pflugeisen, Chaya and Gao, Hongyuan and Winer, Rachel L and Ornelas, India J and Smith, Cynthia and Neslund-Dudas, Christine and Shetty, Punith and Raghavan, Uma G},
title = {Measuring the Validity of Survey Questions on Breast, Cervical, Colorectal, and Lung Cancer Screening},
journal = {American Journal of Epidemiology},
year = {2026},
doi = {10.1093/aje/kwag040}
}
EUVIMED